MediciNova Inc (MNOV) stock
MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.31+0.04 (+3.15%)
Close on Nov 20, 2026Market cap $64.48MP/E –Yield –
MediciNova free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
MediciNova's free cash flow for the twelve months ending Jun 30, 2026 was -$9.12M. For fiscal 2025 it was -$9.81M. The highest annual figure on record is $813.01K in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.81M | – |
| FY2024 | Dec 31, 2024 | -$10.64M | – |
| FY2023 | Dec 31, 2023 | -$7.45M | – |
| FY2022 | Dec 31, 2022 | -$12.92M | – |
| FY2021 | Dec 31, 2021 | -$9.41M | – |
| FY2020 | Dec 31, 2020 | -$10.86M | – |
| FY2019 | Dec 31, 2019 | -$9.14M | – |
| FY2018 | Dec 31, 2018 | -$9.12M | – |
| FY2016 | Dec 31, 2016 | -$6.63M | – |
| FY2015 | Dec 31, 2015 | -$7.15M | -980.0% |
| FY2014 | Dec 31, 2014 | $813.01K | – |
| FY2013 | Dec 31, 2013 | -$10.69M | – |
| FY2012 | Dec 31, 2012 | -$11.95M | – |
| FY2011 | Dec 31, 2011 | -$13.31M | – |
| FY2010 | Dec 31, 2010 | -$17.72M | – |
| FY2009 | Dec 31, 2009 | -$17.03M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.48M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.02M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.31M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.78M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.93M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$499.04K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.37M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.64M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.02M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.98M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.09M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.88M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.41M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.04M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.65M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.03M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.64M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.74M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.65M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.09M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.08M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.62M | – |
See a number that looks wrong?